Skip to main content
news

HKBU and China Resources Enterprise Limited sign MOU to promote the modernisation and internationalisation of Chinese medicine

BACK
Prof Lyu

HKBU has signed a Memorandum of Understanding (MOU) with China Resources Enterprise Limited (CRE) to jointly promote the modernisation and internationalisation of Chinese medicine. Under the MOU’s collaboration framework, the two parties signed a Letter of Intent to explore the establishment of the HKBU-CRE Joint Innovation Centre on Smart Chinese Medicine.

 

The collaboration between HKBU and CRE aims to build on Hong Kong’s status as the nation’s connecting window and bridge with the international community. The initiative also hopes to integrate the strengths of both parties to jointly promote the standardisation, modernisation and scientific development of Chinese medicine, so that Chinese medicine will be more widely accepted by the international community. In addition, this will enable Chinese medicine to further contribute to the safeguarding of human health.

 

Looking ahead, HKBU and CRE will explore knowledge exchange and collaboration on smart Chinese medicine, research and development of modern Chinese medicine and the intellectual property of Chinese medicine and pharmacy. During the five-year collaboration period, the University will utilise its academic and scientific research resources, as well as relevant education, research and development, and medical organisation networks to promote related collaborations. CRE will invest funding of up to HK$50 million and offer market demand and industry knowledge, industry resources as well as management experience to drive relevant collaboration projects.

 

HKBU and CRE will also explore the possibility of establishing the HKBU-CRE Joint Innovation Centre of Smart Chinese Medicine together to take forward related collaborative research, technology development, application and commercialisation initiatives, and promote the digitalisation, standardisation and internationalisation of Chinese medicine.

Please click here for details.